Notice of Cipher Pharmaceuticals Q4 2019 Conference Call

February 20, 2020 |

1 min read

OAKVILLE, ON , Feb. 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (“Cipher” or “the Company”) today announced the details of its Q4 2020 financial results conference call on Thursday, March 26, 2019 . CONFERENCE CALL DETAILS DATE: Thursday, March 26, 2020 TIME: 8:30 a.m.

OAKVILLE, ON, Feb. 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (“Cipher” or “the Company”) today announced the details of its Q4 2020 financial results conference call on Thursday, March 26, 2019.

CONFERENCE CALL DETAILS

DATE:	Thursday, March 26, 2020
TIME:	8:30 a.m. EDT
DIAL IN NUMBER:	(416) 764-8688 or (888) 390-0546
CONFERENCE ID:	02880904
REPLAY:	(888) 390-0541 (playback code 880904 #)
	Available until midnight April 2, 2020
WEBCAST:	The audio webcast can be accessed at http://cipher.investorroom.com/ under Investor Relations or at https://event.on24.com/wcc/r/2203231/4C6EB61DB02BC18A6F5927498CF2787D

About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Company Codes: OtherOTC:CPHRF, Toronto:CPH

Events